Leptin deficiency - Lessons in regional differences in the regulation of bone mass

Bone

Volumn 34, Issue 3, 2004, Pages 369-371

  Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLUCOCORTICOID; INSULIN; LEPTIN; LEPTIN RECEPTOR; SEX HORMONE;

ADIPOCYTE; BODY WEIGHT; BONE DENSITY; BONE MARROW; BONE MASS; BONE METABOLISM; BONE TURNOVER; BRAIN THIRD VENTRICLE; CENTRAL NERVOUS SYSTEM; FRAGILITY FRACTURE; HISTOLOGY; HOMEOSTASIS; INSULIN RELEASE; LUMBAR SPINE; METAPHYSIS; NONHUMAN; PHENOTYPE; REVIEW; SKELETON; TRABECULAR BONE;

EID: 1542376122     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2003.11.007     Document Type: Editorial

References (25)

1. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Thomas G.P., Gardiner E.M.et al. Hypothalamic Y2 receptors regulate bone formation. J. Clin. Invest. 109:2002;915-921.
2. Cornish J., Callon K., Bava U., Grey A., Xu X., Buchanan C.M.et al. The novel hormone, preptin, is another bone-active product of the pancreatic beta cell. J. Bone Miner. Res. 17(Suppl. 1):2002;s428.
3. Cornish J., Callon K.E., Bava U., Lin C., Naot D., Hill B.L.et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 175:2002;405-415.
4. Cornish J., Callon K.E., Cooper G.J., Reid I.R. Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem. Biophys. Res. Commun. 207:1995;133-139.
5. Cui Q., Wang G., Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J. Bone Joint Surg. Am. 79:1997;1054-1063.
6. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 100:2000;197-207.
7. Ensrud K.E., Lipschutz R.C., Cauley J.A., Seeley D., Nevitt M.C., Scott J.et al. Body size and hip fracture risk in older women - A prospective study. Am. J. Med. 103:1997;274-280.
8. Foldes J., Shih M.S., Levy J. Bone structure and calcium metabolism in obese Zucker rats. Int. J. Obes. Relat. Metab. Disord. 16:1992;95-102.
9. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6-depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83:1998;847-850.
10. Hassager C., Christiansen C. Influence of soft tissue body composition on bone mass and metabolism. Bone. 10:1989;415-419.
11. Holloway W.R., Collier F.M., Aitken C.J., Myers D.E., Hodge J.M., Malakellis M.et al. Leptin inhibits osteoclast generation. J. Bone Miner. Res. 17:2002;200-209.
12. Lau E.M.C., Chan Y.H., Chan M., Woo J., Griffith J., Chan H.H.L.et al. Vertebral deformity in Chinese men: prevalence, risk factors, bone mineral density, and body composition measurements. Calcif. Tissue Int. 66:2000;47-52.
13. Lorentzon R., Alehagen U., Boquist L. Osteopenia in mice with genetic diabetes. Diabetes Res. Clin. Pract. 2:1986;157-163.
14. Mathey J., Horcajada-Molteni M.N., Chanteranne B., Picherit C., Puel C., Lebecque P.et al. Bone mass in obese diabetic Zucker rats: influence of treadmill running. Calcif. Tissue Int. 70:2002;305-311.
15. Reid I.R. Relationships among body mass, its components, and bone. Bone. 31:2002;547-555.
16. Reid I.R., Ames R., Evans M.C., Sharpe S., Gamble G., France J.T.et al. Determinants of total body and regional bone mineral density in normal postmenopausal women - A key role for fat mass. J. Clin. Endocrinol. Metab. 75:1992;45-51.
17. Reid I.R., Ames R.W., Evans M.C., Sharpe S.J., Gamble G.D. Determinants of the rate of bone loss in normal postmenopausal women. J. Clin. Endocrinol. Metab. 79:1994;950-954.
18. Reid I.R., Evans M.C., Cooper G.J., Ames R.W., Stapleton J. Circulating insulin levels are related to bone density in normal postmenopausal women. Am. J. Physiol. 265:1993;E655-E659.
19. Reseland J.E., Gordeladze J.O., Drevon C.A. Leptin receptor (OB-R) gene expression in human primary osteoblasts: reaffirmation. J. Bone Miner. Res. 17:2002;1136.
20. Sainsbury A., Baldock P.A., Schwarzer C., Ueno N., Enriquez R.F., Couzens M.et al. Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice. Mol. Cell. Biol. 23:2003;5225-5233.
21. Schott A.M., Cormier C., Hans D., Favier F., Hausherr E., Dargent-Molina P.et al. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS prospective study. Osteoporos. Int. 8:1998;247-254.
22. Steppan C.M., Crawford D.T., Chidsey-Frink K.L., Ke H.Z., Swick A.G. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul. Pept. 92:2000;73-78.
23. Stolk R.P., Vandaele P.L.A., Pols H.A.P., Burger H., Hofman A., Birkenhager J.C.et al. Hyperinsulinemia and bone mineral density in an elderly population - The Rotterdam study. Bone. 18:1996;545-549.
24. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L.et al. Leptin regulates bone formation via the sympathetic nervous system. Cell. 111:2002;305-317.
25. Thomas T., Gori F., Khosla S., Jensen M.D., Burguera B., Riggs B.L. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology. 140:1999;1630-1638.